TICKERNERD
Menu
CRAICRAIIndustrials · Consulting Services

CRAI Stock Forecast: CRA International, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$176
−1.91% on the day

The 2 Wall Street analysts covering CRA International, Inc. hold a median 12-month price target of $251 — +42.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 45 of 100 as at 14 Oct 2026 — in the lower half.

Market cap
$1.1B
Ticker Nerd rank
45 / 100
Median analyst target
$251
Analysts covering
2
Revenue$210.8M+12.8% y/y
Operating income$23.5M
Net income$13.5M
Free cash flow−$6.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+0.4%
1M
+5.8%
YTD
−11.6%
1Y
+0.2%
From 52W high
−20.6%
From 52W low
+28.4%
$137
$221
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CRAI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores CRA International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
45 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
92
Quality
67
Value
59
Issuance
52
Revisions
52
Growth
43
Size
42
Momentum
42
Accruals
26

Volatility (92): The share price has been relatively steady.

Accruals (26): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CRAI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CRAI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$140$160$180$200$220$240$260Jan 26Apr 26Jul 26Oct 26CRAIHigh $256Median $251Low $245

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
1 Buy1 Hold0 Sell
Low $245Median $251High $256

The green dot is the last close — the median target sits +42.7% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
2 Mar 2026Barrington ResearchMaintainsOutperform$245
5 Jan 2026Barrington ResearchMaintainsOutperform—
24 Nov 2025Barrington ResearchMaintainsOutperform—
3 Nov 2025Barrington ResearchMaintainsOutperform—
23 Sept 2025Barrington ResearchMaintainsOutperform—
21 May 2025Barrington ResearchMaintainsOutperform—
24 Feb 2025Barrington ResearchMaintainsOutperform—
8 Nov 2024Barrington ResearchMaintainsOutperform—
11 June 2024Barrington ResearchReiteratesOutperform—
20 May 2024Barrington ResearchMaintainsOutperform—
7 Mar 2024Barrington ResearchMaintainsOutperform—
8 Aug 2023Barrington ResearchReiteratesOutperform—
12 May 2023Barrington ResearchReiteratesOutperform—
7 Nov 2022Barrington ResearchMaintainsOutperform—
8 Aug 2022Barrington ResearchMaintainsOutperform—
8 Mar 2022Barrington ResearchReiteratesOutperform—
24 July 2019Barrington ResearchInitiatesOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CRAI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CRAI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, CRA International, Inc. returned +0.2% against +17.5% for the S&P 500, dividends included.

CRAI vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Jan 26Apr 26Jul 26Oct 26CRAIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CRAI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−1.5%
Analysts raising
1
Analysts cutting
2
Fundamentals

CRA International, Inc. (CRAI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
23.9×

Cheaper than 31% of US stocks

Price / sales
1.4×

Cheaper than 60% of US stocks

Price / book
6.2×

Cheaper than 16% of US stocks

EV / EBITDA
15.0×

Cheaper than 22% of US stocks

Growth & margins
Revenue growth (YoY)
12.8%

Higher than 58% of US stocks

Earnings growth (YoY)
11.4%

Higher than 49% of US stocks

Gross margin
29.4%

Higher than 33% of US stocks

Operating margin
11.2%

Higher than 66% of US stocks

Net margin
6.2%

Higher than 63% of US stocks

Returns & dividend
Return on equity
26.0%

Higher than 86% of US stocks

Return on assets
7.7%

Higher than 87% of US stocks

Dividend yield
1.3%

Higher than 73% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

CRA International, Inc. (CRAI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • CRA International, Inc. has a market value of $1.1B and an enterprise value of $1.4B.

  • Revenue in the twelve months to 30 June 2026: $794.6M. The latest quarter grew 12.8% year on year.

  • Net income over the same four quarters: $49.3M, a 6.2% net margin.

  • Diluted earnings per share, trailing twelve months: $7.51.

  • Free cash flow in the twelve months to 30 June 2026: −$27.7M.

  • CRA International, Inc. spent $53.3M on share buybacks and $14.4M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 6.3M.

  • Trailing P/E: 23.9×; forward P/E: 18.7× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 1.27%, paying out 29% of earnings.

  • CRA International, Inc. employs 968 people — $821K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Oct 2026

Data provided by Twelve Data

Peers

CRAI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelConsulting Services
CompanyMarket capTKN rank
CRAICRA International, Inc.$1.1B
45
ICFIICF International, Inc.$1.6B
83
SBCSBC Medical Group Holdings, Inc.$537.9M
75
ROMARoma Green Finance Ltd.$498.6M
19
HURNHuron Consulting Group, Inc.$2.8B
83
FCNFTI Consulting, Inc.$3.9B
79
PPHCPublic Policy Holding Co., Inc.$316.1M
35

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own CRA International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CRAI news & analysis

Charles River Associates (CRA) Bolsters Life Sciences Practice with Appointment of Christopher Zealey as Vice President

Business Wire · 6 Oct 2026positive

Charles River Associates announced that Christopher Zealey has joined the firm as a vice president in its Life Sciences Practice. The excerpt notes his expertise in cross-functional and medical strategic and tactical planning and insight generation.

Why it matters — The appointment adds a senior hire to CRA's Life Sciences Practice, a business area relevant to CRAI watchers.

Charles River Associates Sees AI, Energy and Cybersecurity Fueling Growth

MarketBeat · 5 Oct 2026positive

Charles River Associates (NASDAQ: CRAI) President, CEO and Chairman Paul Maleh said the consulting firm's growth outlook is supported by demand across its legal, regulatory and management consulting businesses, including opportunities tied to AI, energy infrastructure, life sciences and cybersecurity.

Why it matters — A CRAI watcher would care because management is signaling sustained demand and growth opportunities across multiple business lines and emerging sectors.

CRAI Stock Rises 12.4% in Three Months: Here's What You Should Know

Zacks Investment Research · 1 Oct 2026positive

CRAI stock rose 12.4% over the past three months, supported by broad-based demand, margin expansion, a raised fiscal 2026 revenue outlook, and consistent capital returns to shareholders, according to Zacks Investment Research.

Why it matters — A CRAI watcher would care because the stock's gain reflects improving underlying fundamentals and a more favorable company outlook.

Charles River Associates (CRA) Adds Harvard Business School Professor as Academic Affiliate to Antitrust & Competition Economics Practice

Business Wire · 1 Oct 2026positive

Charles River Associates (NASDAQ: CRAI) announced that Professor Feng Zhu, a Harvard Business School professor, has joined the firm as an Academic Affiliate in its Antitrust & Competition Economics Practice. President and CEO Paul Maleh welcomed Zhu, noting his recognized expertise in digital transformation and competitive strategy.

Why it matters — The addition of a prominent Harvard Business School professor to its antitrust practice could strengthen CRA's expertise and reputation in that consulting area.

Charles River Associates (CRA) Names Patrick Hillan Vice President, Expanding Life Sciences Commercial Strategy Expertise

Business Wire · 29 Sept 2026positive

Charles River Associates announced that Patrick Hillan has joined the firm as a Vice President in its Life Sciences Practice. Hillan brings expertise in medical affairs strategy from his work with global pharmaceutical and biotechnology companies.

Why it matters — CRAI watchers would care because adding a senior life sciences executive expands the firm's commercial strategy expertise in a key practice area.

FAQ

Frequently asked questions about CRAI stock

What is the CRAI stock price forecast for 2026-2027?

The 2 Wall Street analysts covering CRA International, Inc. have a median 12-month price target of $251, with estimates ranging from $245 to $256. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CRAI stock a buy right now?

Of the 2 analysts covering CRA International, Inc., 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks CRA International, Inc. 45 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CRAI?

As at 14 Oct 2026, CRA International, Inc. ranks 45 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (92 of 100).

Will CRAI stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +42.7% from the last close, and Ticker Nerd's factor model ranks CRA International, Inc. 45 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CRAI stock forecast for 2030?

No analyst covering CRA International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CRAI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $245 to $256 over the next 12 months.

How has CRAI stock performed over the past year?

CRA International, Inc. returned +0.2% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does CRA International, Inc. do?

CRA International, Inc. is a global consulting firm that provides economic, financial, and management consulting services to corporations, law firms, accounting firms, and government clients.

What is the latest news on CRAI?

The most recent item we track (Business Wire, 6 Oct 2026): "Charles River Associates (CRA) Bolsters Life Sciences Practice with Appointment of Christopher Zealey as Vice President". Charles River Associates announced that Christopher Zealey has joined the firm as a vice president in its Life Sciences Practice. The excerpt notes his expertise in cross-functional and medical strategic and tactical planning and insight generation.

Company

About CRA International, Inc.

CRA International, Inc. is a global consulting firm that provides economic, financial, and management consulting services to corporations, law firms, accounting firms, and government clients. Its work is organized around litigation and regulatory consulting as well as management consulting, with services that include economic analysis, expert testimony, valuation, risk assessment, and support for strategy and business performance decisions. The company serves a wide range of industries, including finance, healthcare, energy, technology, life sciences, and telecommunications. CRA International, Inc. plays a specialized role in markets where complex disputes, regulatory questions, and analytical decision-making require independent, research-based advice. Headquartered in Boston, Massachusetts, the firm operates internationally under the Charles River Associates brand.

CEO Mr. Paul A. Maleh · 968 employees · United States · https://www.crai.com